Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY1R | P25929 | 1/20 | 0.58 |
| ▸ | NPY2R | P49146 | 1/20 | 0.58 |
| ▸ | NPY4R | P50391 | 1/20 | 0.58 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.58 |
| ▸ | CALCRL | Q16602 | 1/20 | 0.55 |
| ▸ | NTSR2 | O95665 | 15/20 | 0.54 |
| ▸ | NTSR1 | P30989 | 15/20 | 0.54 |
| ▸ | SORT1 | Q99523 | 13/20 | 0.54 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.53 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.52 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.52 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29678167 | 0.89 | CAPN1 (0.48) | NPY1RNPY2RNPY4RNPY5RCALCRL | |
| SCHEMBL29678075 | 0.84 | MAPK8 (0.47) | CALCRLNTSR2NTSR1SORT1 | |
| SCHEMBL29976151 | 0.83 | CALCRL (0.44) | CALCRLNTSR2NTSR1SORT1 | |
| SCHEMBL31472961 | 0.83 | NTSR1 (0.63) | NTSR2NTSR1SORT1OPRM1OPRD1 | |
| SCHEMBL30607280 | 0.83 | CALCR (0.59) | NPY1RNPY2RNPY4RNPY5RCALCRL | |
| SCHEMBL30567788 | 0.83 | EP300 (0.58) | NPY1RNPY2RNPY4RNPY5RNTSR2 | |
| SCHEMBL31233933 | 0.81 | SLC6A2 (0.61) | CALCRLNTSR2NTSR1SORT1SLC6A2 | |
| SCHEMBL31233948 | 0.81 | SLC6A2 (0.61) | CALCRLNTSR2NTSR1SORT1SLC6A2 | |
| SCHEMBL31679338 | 0.81 | SLC6A2 (0.60) | NTSR2NTSR1SORT1SLC6A2OPRM1 | |
| SCHEMBL31257015 | 0.81 | SLC6A2 (0.62) | CALCRLNTSR2NTSR1SORT1SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4003403-A1 | RECEPTOR-TARGETING PEPTIDE-DRUG CONJUGATES | Molgenie GmbH (DE) | 2022-06-01 | — | — | EP | claimed |